Correlates of property crime in a cohort of recently released prisoners with a history of injecting drug use

Harm Reduction Journal

Mark Stoové³  Paul Dietze³  Stuart A. Kinner¹  Rebecca Winter³  Brendan Quinn³  Amy Kirwan² 

[1] School of Medicine, University of Queensland, Brisbane, Queensland, Australia;Centre for Population Health, Burnet Institute, 85 Commercial Rd, Melbourne 3004, Victoria, Australia;School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia

关键词: Crime;    Drug use;    Injecting;    Prison;   

Others  :  1223382
DOI  :  10.1186/s12954-015-0057-y

 received in 2015-02-23, accepted in 2015-07-13,  发布年份 2015

【 摘 要 】

Background

Injecting drug use (IDU) is a strong predictor of recidivism and re-incarceration in ex-prisoners. Although the links between drug use and crime are well documented, studies examining post-release criminal activity and re-incarceration risk among ex-prisoners with a history of IDU are limited. We aimed to explore factors associated with property crime among people with a history of IDU recently released from prison.

Method

Individuals with a history of IDU released from prison within the past month were recruited via targeted and snowball sampling methods from street drug markets and services for people who inject drugs (PWID) into a 6-month cohort study. A multivariate logistic regression analysis of baseline data identified adjusted associations with self-reported property crime soon after release.

Results

Interviews were conducted a median of 23 days post-release with 141 participants. Twenty-eight percent reported property crime in this period and 85 % had injected drugs since release. Twenty-three percent reported injecting at least daily. Reporting daily injecting (adjusted odds ratio (aOR) 4.36; 95 % confidence interval (CI) = 1.45–13.07), illicit benzodiazepine use (aOR = 2.59; 95 % CI = 1.02–5.67), being arrested (aOR = 6.12; 95 % CI = 1.83–20.45) and contact with mental health services (aOR = 4.27; 95 % CI = 1.45–12.60) since release were associated with property crime.

Conclusion

Criminal activity soon after release was common in this sample of PWID, underscoring the need for improved pre-release, transitional and post-release drug use dependence and prevention programmes. Addressing co-occurring mental disorder and poly-pharmaceutical misuse among those with a history of IDU in prison, and during the transition to the community, may reduce property crime in this group.

【 授权许可】

   
2015 Kirwan et al.

【 参考文献 】

• [1]Statistical profile of the Victorian prison system. Victorian Department of Justice, Melbourne; 2009.
• [2]The health of Australia’s prisoners 2012. Australian Institute of Health and Welfare, Canberra; 2013.
• [3]Dowden C, Brown S. The role of substance abuse factors in predicting recidivism: a meta-analysis. Psychol, Crime and Law. 2002; 8(3):243-64.
• [4]Passey M. Evaluation of the Lismore MERIT Pilot Program - final report. Northern Rivers University Department of Rural Health, Lismore, Australia; 2003.
• [5]Kinner SA. The post-release experience of prisoners in Queensland. Trends and Issues in Crime and Crim Justice. 2006; 325:1-6.
• [6]Larney S, Toson B, Burns L, Dolan K. Opioid substitution treatment in prison and post-release: effects on criminal recidivism and mortality. National Drug Law Enforcement Research Fund, Commonwealth of Australia, Canberra; 2011.
• [7]Stafford J, Burns L, Trends AD. Findings from the Illicit Drug Reporting System (IDRS), in Australian Drug Trends Series 2012. National Drug and Alcohol Research Centre, University of New South Wales, Sydney; 2011.
• [8]Kinner SA, George J, Campbell G, Degenhardt L. Crime, drugs and distress: patterns of drug use and harm among criminally involved injecting drug users in Australia. Aust N Z J Public Health. 2009; 33(3):223-7.
• [9]Bennett T, Holloway K, Farrington D. The statistical association between drug misuse and crime: a meta-analysis. Aggression and Violent Behav. 2008; 13:107-18.
• [10]Gottfredson DC, Kearley BW, Bushway SD. Substance use, drug treatment and crime: an examination of intra-individual variation in a drug court population. J Drug Issues. 2008; 38(2):601-30.
• [11]Goldstein PJ. The drugs/violence nexus: a tripartite conceptual framework. J Drug Issues. 1985; 39:143-74.
• [12]Gaffney A, Jones W, Sweeney J, Payne J. Drug use monitoring in Australia: 2008 annual report on drug use among police detainees. Australian Institute of Criminology, Canberra; 2010.
• [13]Payne J, Gaffney A. How much crime is drug and alcohol related? Self-reported attributions of police detainees. Trends and Issues in Crime and Crim Justice. 2012; 439:1-6.
• [14]Horyniak D, Higgs P, Jenkinson R, Degenhardt L, Stoové M, Kerr T, Hickman M, Aitken C, Dietze P. Establishing the Melbourne Injecting Drug User Cohort Study (MIX): rationale, methods, and baseline and twelve-month follow-up results. Harm Reduction J. 2012; 10:11. BioMed Central Full Text
• [15]Fry C, Ritter A, Baldwin S, Bowen K, Gardiner P, Holt T, Jenkinson R, Johnston J. Paying research participants: a study of current practices in Australia. J Med Ethics. 2005; 31:542-7.
• [16]Kessler RC, Barker PR, Colpe LJ, Epstein JF, Gfroerer JC, Hiripi E, Howes MJ, Normand S-LT, Manderscheid RW, Walters EE, Zaslavsky AM. Screening for serious mental illness in the general population. Arch Gen Psychiatry. 2003; 60(2):184-9.
• [17]Nielsen S, Bruno R, Carruthers S, Fishcer J, Lintzeris N, Stoové M. Investigation of pharmaceutical misuse amongst drug treatment clients. Melbourne, Turning Point Alcohol and Drug Centre; 2008.
• [18]Loxley W. Benzodiazepine use and harms among police detainees in Australia. Trends and Issues in Crime and Crim Justice. 2007;336. Available at:. http://aic. gov.au/publications/current%20series/tandi/321-340/tandi336.html webcite
• [19]Chen KW, Berger CC, Forde DP, D’Adamo C, Weintraub E, Gandhi D. Benzodiazepine use and misuse among patients in a methadone program. BMC Psychiatry. 2011; 11(1):90. BioMed Central Full Text
• [20]Eiroa-Orosa FJ, Haasen C, Verthein U, Dilg C, Schäfer I, Reimer J. Benzodiazepine use among patients in heroin-assisted vs. methadone maintenance treatment: findings of the German randomized controlled trial. Drug Alcohol Depend. 2010; 112(3):226-33.
• [21]Fernandez Sobrino AM, Fernández Rodríguez V. Benzodiazepine use in a sample of patients on a treatment program with opiate derivatives (PTDO). Adicciones. 2009; 21(2):143.
• [22]Lavie E, Fatséas M, Denis C, Auriacombe M. Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: correlates of use, abuse and dependence. Drug Alcohol Depend. 2009; 99(1):338-44.
• [23]Specka M, Bonnet U, Heilmann M, Schifano F, Scherbaum N. Longitudinal patterns of benzodiazepine consumption in a German cohort of methadone maintenance treatment patients. Human Psychopharmacol: Clin Exp. 2011; 26(6):404-11.
• [24]Jones JD, Mogali S, Comer SD. Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug Alcohol Depend. 2012; 125:8-18.
• [25]Smith B, Miller P, O’Keefe B, Fry C. Benzodiazepine and pharmaceutical opioid misuse and their relationship to crime: Victorian report. NDLERF Monograph 23, 2007, National Drug Law Enforcement Research Fund: Canberra. Available at:. http://www. ndlerf.gov.au/publications/monographs/monograph-23 webcite
• [26]Nielsen S, Bruno R, Degenhardt L, Stoové M, Fischer J, Carruthers S, Lintzeris N. The source of pharmaceuticals for problematic users of prescription opioids and benzodiazepines. Med J Aust. 2013; 199(10):696-9.
• [27]Nielsen S, Dietze P, Lee N, Dunlop A, Taylor D. Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment. Addiction. 2007; 102(4):616-22.
• [28]Shand F, Campbell G, Hall W, Lintzeris N, Cohen M, Degenhardt L. Real time monitoring of Schedule 8 medicines in Australia. Med J Aust. 2013; 198(2):80-1.
• [29]White P, Whiteford H. Prisons: mental health institutions of the 21st century? Med J Aust. 2006; 185(6):302-3.
• [30]Butler T, Indig D, Allnutt S, Mamoon H. Co-occurring mental illness and substance use disorder among Australian prisoners. Drug Alcohol Rev. 2011; 30:188-94.
• [31]Mullen PE, Burgess P, Wallace C. Community care and criminal offending in schizophrenia. Lancet. 2000; 355:614-7.
• [32]Mullen P. A review of the relationship between mental disorders and offending behaviours on the management of mentally abnormal offenders in the health and criminal justice system. Criminology Research Council, Canberra; 2001.
• [33]Schildersab MR, Ogloff J. Review of point-of-reception mental health screening outcomes in an Australian prison. J Forensic Psychiatry Psychol. 2014; 25(4):480-94.